Competitive problems in the drug industry: hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninety-first Congress, first session ...
United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and Anticompetitive Activities, United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly
U.S. Government Printing Office, 1967 - Pharmaceutical industry
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
accordance action active additional agencies applicable approved assay Association assure batch bioavailability Capsules central Classification of Defects Color Company compliance container contract contractor cost Defense Department designated determined developed digoxin DPSC Drug Administration drug products effective established Explanatory Notes Federal firms Food and Drug Government Gram Health Hydrochloride immediate indicated industry ingredient Injection inspection issue label Laboratories Labs letter limits manufacturing manufacturing practices material Medical meet methods Office package Patent percent performance Pharmaceutical preparation present problem procedures procurement purchase quantity question recommendations records regulations request requirements response result samples Senator NELsoN Sodium solution sources specifications standards statement submitted supply Tablets tion uniformity unit